Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-09-18

FDA Approved: ZOLPIDEM — Supplemental Application (ACI Healthcare USA, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Zolpidem tartrate, indicating changes to the labeling for Zolpidem.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem (zolpidem)

Snippet

SUPPL AP for ZOLPIDEM (ZOLPIDEM TARTRATE)